Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aquestive, Blueprint, Chiesi, Kleo, Neurosense, Novan, Protalix, Realta, Revance.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bioxcel, Vivus.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: CHF Solutions, Eyeyon Medical.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Astellas, CSL, Exelixis, Fibrogen, Mesoblast, Seqirus, Takeda

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Axonics Modulation Technologies, Drawbridge Health, Qiagen, Sky Medical, Soundbite Medical Solutions.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anavex, Biocryst, Glycomimetics.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Medalliance.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aimmune, Cormedix, CTI, Glaxosmithkline, GW, Merck, Mesoblast, Resverlogix, Scancell, Seqirus, Therapeuticsmd.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Olympus.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Alnylam, Bayer, Daiichi Sankyo, Emergent Biosolutions, Lilly, Novo Nordisk, Pfizer, Seattle Genetics.